David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
2001
Nova
NVMI
$11.7B
| $2.62M | ﹤0.01% |
102,500
+50,971
| +99% | +$1.36M |
|
2002
Jazz Pharmaceuticals
JAZZ
$16.2B
| $2.62M | ﹤0.01% |
18,380
-73,446
| -80% | -$9.87M |
|
2003
CALL
HF Sinclair
DINO
$17.2B
| $2.62M | ﹤0.01% |
56,500
-20,600
| -27% | -$920K |
|
2004
PUT
Ralph Lauren
RL
$21.6B
| $2.61M | ﹤0.01% |
23,000
| – | – |
|
2005
PUT
Wolfspeed
WOLF
$1.4B
| $2.61M | ﹤0.01% |
46,500
+33,900
| +269% | +$2.07M |
|
2006
FerroAtlántica
GSM
$761M
| $2.61M | ﹤0.01% |
1,534,839
-405,750
| -21% | -$773K |
|
2007
Clearway Energy Class C
CWEN
$6.67B
| $2.61M | ﹤0.01% |
154,680
-307,691
| -67% | -$4.86M |
|
2008
Gogo Inc
GOGO
$386M
| $2.6M | ﹤0.01% |
654,260
+153,003
| +31% | +$743K |
|
2009
CALL
Microchip Technology
MCHP
$40.2B
| $2.6M | ﹤0.01% |
60,000
+20,000
| +50% | +$889K |
|
2010
Diodes
DIOD
$4.17B
| $2.6M | ﹤0.01% |
71,350
-24,988
| -26% | -$884K |
|
2011
Werner Enterprises
WERN
$2.33B
| $2.59M | ﹤0.01% |
83,433
-97,509
| -54% | -$3.15M |
|
2012
Aurinia Pharmaceuticals
AUPH
$2.2B
| $2.59M | ﹤0.01% |
393,300
-154,898
| -28% | -$987K |
|
2013
Center Bancorp
CNOB
$1.61B
| $2.58M | ﹤0.01% |
114,107
-2,916
| -2% | -$62.9K |
|
2014
PUT
LyondellBasell Industries
LYB
$20.2B
| $2.58M | ﹤0.01% |
30,000
+13,600
| +83% | +$1.16M |
|
2015
Astronics
ATRO
$3.33B
| $2.58M | ﹤0.01% |
76,990
+55,815
| +264% | +$1.75M |
|
|
ANAT
2016
PUT
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.57M | ﹤0.01% |
22,100
+10,600
| +92% | +$1.23M |
|
2017
Lindsay Corp
LNN
$1.16B
| $2.57M | ﹤0.01% |
31,286
+2,111
| +7% | +$177K |
|
2018
Brown & Brown
BRO
$24.4B
| $2.57M | ﹤0.01% |
76,600
+35,820
| +88% | +$1.14M |
|
2019
ICU Medical
ICUI
$4.49B
| $2.56M | ﹤0.01% |
10,150
+5,516
| +119% | +$1.28M |
|
2020
Liberty Latin America Class C
LILAK
$1.68B
| $2.55M | ﹤0.01% |
173,384
+159,693
| +1,166% | +$2.61M |
|
2021
Akebia Therapeutics
AKBA
$251M
| $2.55M | ﹤0.01% |
526,592
+174,805
| +50% | +$994K |
|
2022
PUT
Cboe Global Markets
CBOE
$32.6B
| $2.54M | ﹤0.01% |
24,500
| – | – |
|
2023
Baxter International
BAX
$13.7B
| $2.54M | ﹤0.01% |
31,037
-174,042
| -85% | -$13.5M |
|
2024
CALL
Alnylam Pharmaceuticals
ALNY
$32B
| $2.54M | ﹤0.01% |
35,000
-20,000
| -36% | -$1.53M |
|
2025
PUT
Wayfair
W
$14.2B
| $2.54M | ﹤0.01% |
17,400
+400
| +2% | +$60.2K |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.